Inge van der Werf
Impact in
-
- Acute Myeloid Leukemia Research
-
- Cancer-related molecular mechanisms research
Papers in
-
- RNA Research and Splicing 8
- RNA modifications and cancer 3
- RNA regulation and disease 3
-
- Acute Myeloid Leukemia Research 8
- Co-authors
- Catriona Jamieson (8 shared papers)Bernadette A. Chua (1 shared paper)Robert Signer (1 shared paper)Jacqueline Cloos (7 shared papers)Larisa Balaian (4 shared papers)Leslie Crews (3 shared papers)Michael D. Burkart (4 shared papers)James J. La Clair (2 shared papers)
- Journals
- Blood (4 papers)Cell stem cell (3 papers)Cancers (2 papers)Cell Genomics (1 paper)FEBS Letters (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Inge van der Werf
14 papers receiving 167 citations
Peers
Comparison fields: 5 of 38
- Hematology 46
- Cancer Research 37
- Genetics 20
- Molecular Biology 124
- Aging 2
Countries citing papers authored by Inge van der Werf
This map shows the geographic impact of Inge van der Werf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge van der Werf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge van der Werf more than expected).
Fields of papers citing papers by Inge van der Werf
This network shows the impact of papers produced by Inge van der Werf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge van der Werf. The network helps show where Inge van der Werf may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge van der Werf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 56 | |
| 2 | 2023 | 40 | |
| 3 | 2021 | 23 | |
| 4 | 2023 | 18 | |
| 5 | 2021 | 8 | |
| 6 | 2023 | 7 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 4 | |
| 9 | 2024 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2025 | 1 | |
| 12 | Involvement of SRSF1 in Alternative Splicing of FPGS and Methotrexate Resistance in Children with Acute Lymphoblastic Leukemia | 2015 | 1 |
| 13 | 2023 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2023 | 0 | |
| 16 | 2020 | 0 | |
| 17 | 2022 | 0 |
About Inge van der Werf
Inge van der Werf is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Genetics, having authored 17 papers that have together received 168 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), RNA Research and Splicing (8 papers), Cancer Genomics and Diagnostics (3 papers), RNA modifications and cancer (3 papers), CAR-T cell therapy research (3 papers), RNA regulation and disease (3 papers), MicroRNA in disease regulation (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (46 citations), Cancer Research (37 citations), Genetics (20 citations), Molecular Biology (124 citations) and Aging (2 citations). Inge van der Werf has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Catriona Jamieson, Bernadette A. Chua, Robert Signer, Jacqueline Cloos, Larisa Balaian, Leslie Crews, Michael D. Burkart, James J. La Clair, Jeroen J. W. M. Janssen and Thomas Whisenant. Their work appears in journals such as Blood, Cell stem cell, Cancers, Cell Genomics and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.